South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection, has raised $270 million in Series C funding. Bain Capital Life Sciences and Perceptive Advisors led the round.
Source: Press Release
Freenome lands $270m Series C
South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection, has raised $270 million in Series C funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: